Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LAG3 Protein (AA 23-222) (His-IF2DI Tag)

LAG3 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses WB, ELISA
Catalog No. ABIN7123802
  • Target See all LAG3 Proteins
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 23-222
    Origin
    • 18
    • 11
    • 6
    • 4
    • 1
    • 1
    • 1
    Human
    Source
    • 21
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This LAG3 protein is labelled with His-IF2DI Tag.
    Application
    Western Blotting (WB), ELISA
    Purity
    Greater than 95 % by SDS-PAGE gel analyses
    Sterility
    0.2 μm filtered
    Top Product
    Discover our top product LAG3 Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Storage
    4 °C,-20 °C
    Storage Comment
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Expiry Date
    12 months
  • Target
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Alternative Name
    CD223 (LAG3 Products)
    Synonyms
    CD223 Protein, LAG-3 Protein, Ly66 Protein, lymphocyte activating 3 Protein, lymphocyte-activation gene 3 Protein, LAG3 Protein, Lag3 Protein
    Background
    CD223, CD223 antigen, FDC protein, LAG-3, Lag3, LAG3_HUMAN, Lymphocyte activating 3, Lymphocyte activation gene 3, Lymphocyte activation gene 3 protein, Protein FDC
    Molecular Weight
    42.5 kDa
    UniProt
    P18627
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here: